PROM1 and neoplasm: Rocco et al. have found that although CD133(+) and CD133(+)/CD44(+) expressions were detectable in human primary gastric cancers (GCs), they either did not explicit stem cell properties or demonstrate tumor-initiating properties in xenograft transplantation experiments [78].